1. Chile Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Clínica Las Condes S.A.

Clínica Las Condes S.A.

LAS-CONDES.SN
Clínica Las Condes S.A.CL flagSantiago Stock Exchange
11,060.00
CLP
-430.00
- -
112.78BMarket Cap

Total Valuation

Clínica Las Condes S.A. carries a market capitalization of 112.78B, placing it among publicly traded companies globally. Its enterprise value stands at 481.04B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap112.78B
Enterprise Value481.04B

Share Statistics

Clínica Las Condes S.A. currently has 16.26M shares outstanding.

Shares Outstanding16.26M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 1.21, and the price-to-book ratio stands at -55.12.

PE RatioN/A
PS Ratio1.21
PB Ratio-55.12
P/TBV Ratio1.14
P/FCF Ratio260.16
P/OCF RatioN/A

Enterprise Valuation

EV / Sales2.75
EV / EBITDAN/A
EV / EBITN/A
EV / FCF68.12

Financial Position

Clínica Las Condes S.A. maintains a current ratio of 0.64, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 162.42, indicating elevated leverage, while an interest coverage ratio of -5.05 demonstrates limited ability to service its debt obligations.

Current Ratio0.64
Quick Ratio0.21
Debt / Equity162.42
Debt / EBITDA-7.19
Interest Coverage-5.05

Financial Efficiency

Return on Equity (ROE)-701.14
Return on Assets (ROA)-8.09
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover56.36

Taxes

Income Tax-17.09B
Effective Tax RateN/A

Stock Price Statistics

Clínica Las Condes S.A.'s stock has declined approximately -26.26667% over the past 52 weeks. The 50-day moving average sits at 11,114.59, while the 200-day moving average is 14,189.30.

Beta (5Y)N/A
52-Week Price Change-26.26667%
50-Day Moving Average11,114.59
200-Day Moving Average14,189.30
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Clínica Las Condes S.A. generated 174.90B in revenue and converted that into -48.24B in net income, yielding earnings per share of -3,076.93. EBITDA reached -42.41B, while operating income came in at -42.41B.

Revenue174.90B
Gross Profit21.23B
Operating Income-42.41B
Pretax Income-66.60B
Net Income-48.24B
EBITDA-42.41B
EBIT-42.41B
Earnings Per Share (EPS)-3,076.93

Balance Sheet

Clínica Las Condes S.A. holds 35.02B in cash and equivalents against 304.91B in total debt, resulting in a net debt position of 290.13B. Total book value stands at -3.85B, with working capital of -59.48B providing operational flexibility.

Cash & Cash Equivalents35.02B
Total Debt304.91B
Net Debt290.13B
Equity (Book Value)-3.85B
Book Value Per Share-239.48
Working Capital-59.48B

Cash Flow

After subtracting -816.33M in capital expenditures, free cash flow totaled -816.33M - equivalent to -50.74 per share.

Operating Cash FlowN/A
Capital Expenditures-816.33M
Free Cash Flow-816.33M
FCF Per Share-50.74

Margins

Clínica Las Condes S.A. operates with a gross margin of 12.14, reflecting its pricing power and cost economics. The operating margin of -24.25 and net profit margin of -27.58 provide insight into operational efficiency.

Gross Margin12.14
Operating Margin-24.25
Pretax Margin-38.08
Profit Margin-27.58
EBITDA Margin-24.25

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-60.58
FCF Yield0.38

Stock Splits

Clínica Las Condes S.A.'s most recent stock split took place on June 25, 2025 with a 1000:1011 split ratio.

Last Split Date6/25/2025
Split Ratio1000:1011

Scores

Clínica Las Condes S.A. posts an Altman Z-Score of -0.12, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.12